Company: ATLN
Filing Date: 2025-12-05
Form Type: S-3
Source: 0001213900-25-118830
Chunk: 26

Company: ATLANTIC INTERNATIONAL CORP.
Filing Date: 2025-12-05
Form: S-3
Chunk 26
---
”).
The Common Stock Purchase warrants (“Warrants”) will be exercisable for five years. The Warrant Exercise Price will equal
the Preferred Stock Conversion Price.

On [ ], 2025, we entered into a certain sales
agreement (the “Sales Agreement”), with [*], relating to shares of our Preferred Stock and Warrants (collectively, our “Securities”)
(offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer
and sell shares of our Preferred Stock having an aggregate offering price of up to $30,000,000 and Warrants to purchase shares of Common
Stock equal to ___% of the number of shares of Common Stock issuable upon conversion of the Preferred Stock.

Our Common Stock is listed on The Nasdaq Global Market under the symbol
“ATLN.” On December 4, 2025, the last reported sale price of our Common Stock on the Nasdaq Global Market was $2.28 per share.

[*] is not required to sell any specific number
or dollar amount of securities but will act as a sales agent using commercially reasonable best efforts consistent with its normal trading
and sales practices, on mutually agreed terms between [*] and us. There is no arrangement for funds to be received in any escrow, trust
or similar arrangement.

The compensation to [*] for sales of Securities
sold pursuant to the sales agreement will be equal to [*] % of the gross proceeds of any shares of Preferred Stock sold under the Sales
Agreement. In connection with the sale of the Securities on our behalf, [*] will be deemed to be an “underwriter” within the
meaning of the Securities Act and the compensation of [*] will be deemed to be underwriting commissions or discounts. We have also agreed
to provide indemnification and contribution to [*] with respect to certain liabilities, including liabilities under the Securities Act
or the Securities Exchange Act of 1934, as amended, or the Exchange Act.

Investing in our Securities involves a high degree of risk. See “Risk Factors” beginning on page S-4 of this prospectus supplement, and under similar headings in the other documents that are incorporated by reference into this prospectus that should be considered in connection with an investment in our Common Stock.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div